TABLE 1.

Baseline table of three types of LMWHs.

	Enoxaparin		Dalteparin		Tinzaparin
	No. of HIT-associated AEs	Percentage	No. of HIT-associated AEs	Percentage	No. of HIT-associated AEs	Percentage
All	242		34		30
Age
<18	2	0.83%	0	0.00%	0	0.00%
18–60	66	27.27%	7	20.59%	7	23.33%
>60	143	59.09%	23	67.65%	16	53.33%
Unknown	31	12.81%	4	11.76%	7	23.33%
Gender
Female	97	40.08%	18	52.94%	13	43.33%
Male	124	51.24%	15	44.12%	16	53.33%
Unknown	21	8.68%	1	2.94%	1	3.33%
Outcome of events
Death	53	21.90%	8	23.53%	11	36.67%
Hospitalization-initial or prolonged/disability/life-threatening	157	64.88%	20	58.82%	14	46.67%
Others	32	13.22%	6	17.65%	5	16.67%
Reporter country
US	93	38.43%	7	20.59%	1	3.33%
Other countries	149	61.57%	27	79.41%	29	96.77%